 NEW YORK, Nov. 10, 2020 GLOBE NEWSWIRE -- Royalty Pharma plc Nasdaq: RPRX today reported financial results for the third quarter of 2020 and updated full-year 2020 guidance for Adjusted Cash Receipts1 a non-GAAP financial measure. 